Childhood Acute Lymphoblastic Leukemia - 25 Studies Found
| Active, not recruiting |
: Childhood Acute Lymphoblastic Leukemia Treatment Protocol Moscow-Berlin 2008 : Childhood Acute Lymphoblastic Leukemia : 2013-09-26 :
|
| Terminated |
: Study in Pediatrics With Relapsed or Refractory Pediatric Acute Lymphoblastic Leukemia (pALL) or Lymphoblastic Lymphoma : B-Cell Pediatric ALL : 2014-08-21 : Drug: Moxetumomab Pasudotox Participants received 6 doses of moxetumomab pasudotox 40 microgram per kilo |
| Recruiting |
: Optimizing 6-mercaptopurine Therapy in Pediatric Acute Lymphoblastic Leukemia by Using Allopurinol : Lymphoblastic Leukemia, Acute, Childhood : 2017-01-09 :
|
| Recruiting |
: Assessing Compliance With Mercaptopurine Treatment in Younger Patients With Acute Lymphoblastic Leukemia in First Remission : Childhood Acute Lymphoblastic Leukemia in Remission : 2012-01-03 :
|
| Terminated |
: Treatment of Childhood Acute Lymphoblastic Leukemia : Acute Lymphoblastic Leukemia : 2005-09-09 :
|
| Completed |
: Renal and Hepatic Clearance Following High-Dose Methotrexate in Childhood ALL : Lymphoblastic Leukemia, Acute, Childhood : 2013-07-08 |
| Completed |
: A Safety and Tolerability Study of Clofarabine, Etoposide, Cyclophosphamide, PEG-asparaginase, and Vincristine in Pediatric Acute Lymphoblastic Leukemia (ALL) : Lymphoblastic Leukemia, Acute, Childhood : 2009-10-05 : Drug: Clofarabine incorporated into a 5-drug regimen Clofarabine (IV) 40mg/m2 into an intensive chemothe |
| Completed |
: Chemoimmunotherapy With Epratuzumab in Relapsed Acute Lymphoblastic Leukemia (ALL) : Recurrent Childhood Acute Lymphoblastic Leukemia : 2004-12-08 :
|
| Completed |
: Alemtuzumab With or Without Methotrexate and Mercaptopurine in Treating Young Patients With Relapsed Acute Lymphoblastic Leukemia : Recurrent Childhood Acute Lymphoblastic Leukemia : 2004-08-04 :
|
| Completed |
: Genomic Changes in Childhood Acute Lymphoblastic Leukemia : Acute Lymphoblastic Leukemia : 2010-03-17 |